TP53 and ovarian carcinoma: Regarding miRs, it was recently demonstrated that in ovarian cancer miR let-7d-5p targets the expression of high mobility group A (HMGA) protein, which in turn affects mutant p53 expression in the mRNA and at the protein level [97].